• Explore /
  • Poster
  • / Efficacy of octreotide LAR (OCT) in patients (pts) with advanced neuroendocrine tumors (NET): A post hoc analysis of the placebo (PBO) arm of the phase III RADIANT-2 study with updated survival data.

Efficacy of octreotide LAR (OCT) in patients (pts) with advanced neuroendocrine tumors (NET): A post hoc analysis of the placebo (PBO) arm of the phase III RADIANT-2 study with updated survival data.

Abstract Poster

Authors

null

Jonathan R. Strosberg

Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL

Jonathan R. Strosberg , James C. Yao , Emilio Bajetta , Mounir Aout , Bert Bakker , John D. Hainsworth , Philippe B. Ruszniewski , Eric Van Cutsem , Kjell E. Oberg , Marianne E. Pavel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT00412061

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 265)

DOI

10.1200/jco.2014.32.3_suppl.265

Abstract #

265

Poster Bd #

B38

Abstract Disclosures

Similar Posters

First Author: James C. Yao

First Author: James Yao

First Author: Lowell Anthony

First Author: Edward Wolin